MetLife Investment Advisors »

Corcept Therapeutics Incorporated shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 42k 32.48
2023-09-30 $1.2M 42k 27.25
2023-06-30 $942k 42k 22.25
2023-03-31 $1.0M 47k 21.66
2022-12-31 $957k 47k 20.31
2022-09-30 $1.2M 47k 25.65
2022-06-30 $1.1M 47k 23.78
2022-03-31 $1.1M 47k 22.53
2021-12-31 $670k 34k 19.80
2021-09-30 $666k 34k 19.68
2021-06-30 $866k 39k 22.00
2021-03-31 $937k 39k 23.79
2020-12-31 $1.0M 39k 26.16
2020-09-30 $756k 43k 17.40
2020-06-30 $731k 43k 16.83
2020-03-31 $517k 43k 11.90
2019-12-31 $526k 43k 12.11
2019-09-30 $614k 43k 14.14
2019-06-30 $484k 43k 11.15
2019-03-31 $510k 43k 11.74
2018-12-31 $580k 43k 13.35
2018-09-30 $945k 67k 14.02
2018-06-30 $683k 43k 15.72
2018-03-31 $715k 43k 16.46
2017-12-31 $785k 43k 18.07